Impaired insulin signaling increases risk of Alzheimer’s disease (Ronnemaa et al., 2008), cognitive disabilities in diabetes mellitus (Seaquist, 2010) whereas intranasal administration of insulin improves hippocampal-dependent memory function (Benedict et al., 2007). The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.